Clinical Trial Update: Measurement of Fibrinogen in Patients With Systemic Inflammatory Response Syndrome (SIRS), Sepsis or Chronicle Liver Disease on Intensive Care Units (ICU)

View source ↗

Summary

This entry reports a clinical trial investigating fibrinogen measurement in ICU patients with SIRS, sepsis, or chronic liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease
• Sepsis
• Systemic Inflammatory Response Syndrome

Snippet

Sponsor: Johann Wolfgang Goethe University Hospital | Conditions: SIRS, Sepsis | Status: UNKNOWN